- Report
- June 2024
- 67 Pages
Brazil
From €4742EUR$4,995USD£4,000GBP
- Report
- June 2024
- 67 Pages
Mexico
From €4742EUR$4,995USD£4,000GBP
- Report
- June 2024
- 70 Pages
Japan
From €4742EUR$4,995USD£4,000GBP
- Report
- June 2024
- 68 Pages
Russia
From €4742EUR$4,995USD£4,000GBP
- Report
- June 2024
- 67 Pages
Spain
From €4742EUR$4,995USD£4,000GBP
- Report
- June 2024
- 125 Pages
United States
From €4742EUR$4,995USD£4,000GBP
The Peripheral Embolic Protection Device (PEP) market is a subset of the Cardiovascular Devices market. PEP devices are used to reduce the risk of stroke and other embolic events during peripheral vascular interventions. These devices are designed to capture and remove embolic debris from the bloodstream, thereby reducing the risk of stroke and other embolic events. PEP devices are typically used in conjunction with other cardiovascular devices, such as stents, balloons, and catheters.
PEP devices are available in a variety of sizes and shapes, and are designed to fit a variety of vascular anatomy. They are typically made of a combination of materials, such as nitinol, stainless steel, and polyurethane. The market for PEP devices is expected to grow in the coming years, driven by the increasing prevalence of peripheral vascular diseases and the growing demand for minimally invasive treatments.
Some of the major players in the PEP device market include Abbott, Boston Scientific, Medtronic, Terumo, and Merit Medical. Show Less Read more